# Prospective Study to Validate the Imaging Biomarker for NCP (R33)

> **NCT05653921** · — · SUSPENDED · sponsor: **Tufts Medical Center** · enrollment: 438 (estimated)

## Conditions studied

- Dry Eye Syndromes
- Corneal Disease

## Interventions

- **OTHER:** In vivo confocal microscopy (IVCM)

## Key facts

- **NCT ID:** NCT05653921
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-12-16
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 438 (ESTIMATED)
- **Why stopped:** PI si leaving institution. This study will likely be transferred to USF but study activity is not continuing at TMC.
- **Last updated:** 2026-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05653921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05653921, "Prospective Study to Validate the Imaging Biomarker for NCP (R33)". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT05653921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*